COEP — Coeptis Therapeutics Holdings Balance Sheet
0.000.00%
- $32.44m
- $33.93m
Annual balance sheet for Coeptis Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K/A | 10-K | 10-K | 10-Q | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.907 | 0.404 | 3.79 | 1.47 | 0.533 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.008 | 0.039 | 0 |
Prepaid Expenses | |||||
Total Current Assets | 0.959 | 0.413 | 3.94 | 1.75 | 1.05 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 0.071 | 0.109 | 0.07 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 76.7 | 76.2 | 7.92 | 4.57 | 8.91 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.005 | 0.14 | 2.17 | 2.99 | 4.51 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 23 | 7.19 | 3.46 | 3.76 | 5.72 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 53.8 | 69 | 4.45 | 0.814 | 3.19 |
Total Liabilities & Shareholders' Equity | 76.7 | 76.2 | 7.92 | 4.57 | 8.91 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |